{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:01:34Z","timestamp":1780970494748,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05008-x","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T04:13:32Z","timestamp":1777176812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemotherapy as a protective factor against cardiocerebrovascular disease mortality in colorectal cancer patients based on SEER database"],"prefix":"10.1007","volume":"17","author":[{"given":"Yingna","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"key":"5008_CR1","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. https:\/\/doi.org\/10.1038\/nrdp.2015.65.","journal-title":"Nat Rev Dis Primers"},{"key":"5008_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104\u201317. https:\/\/doi.org\/10.3322\/caac.21220.","journal-title":"CA Cancer J Clin"},{"key":"5008_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145\u201364. https:\/\/doi.org\/10.3322\/caac.21601.","journal-title":"CA Cancer J Clin"},{"key":"5008_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.21037\/jgo.2019.03.04","volume":"10","author":"K Keramida","year":"2019","unstructured":"Keramida K, Charalampopoulos G, Filippiadis D, Tsougos E, Farmakis D. Cardiovascular complications of metastatic colorectal cancer treatment. J Gastrointest Oncol. 2019;10:797\u2013806. https:\/\/doi.org\/10.21037\/jgo.2019.03.04.","journal-title":"J Gastrointest Oncol"},{"key":"5008_CR5","doi-asserted-by":"publisher","unstructured":"Asnani A, Moslehi JJ, Adhikari BB, Baik AH, Beyer AM, De Boer RA, et al. Preclinical models of cancer therapy\u2013associated cardiovascular toxicity: a scientific statement from the American Heart Association. Circul Res. 2021;129. https:\/\/doi.org\/10.1161\/RES.0000000000000473.","DOI":"10.1161\/RES.0000000000000473"},{"key":"5008_CR6","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamaoncol.2019.0695","volume":"5","author":"JC Brown","year":"2019","unstructured":"Brown JC, Caan BJ, Prado CM, Weltzien E, Xiao J, Cespedes Feliciano EM, et al. Body composition and cardiovascular events in patients with colorectal cancer: a population-based retrospective cohort study. JAMA Oncol. 2019;5:967. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0695.","journal-title":"JAMA Oncol"},{"key":"5008_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/eurheartj\/ehaa779","volume":"42","author":"L Wang","year":"2021","unstructured":"Wang L, Wang F, Chen L, Geng Y, Yu S, Chen Z. Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: an American population-based cohort study. Eur Heart J. 2021;42:101\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa779.","journal-title":"Eur Heart J"},{"key":"5008_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/pbc.23296","volume":"58","author":"PK Prasad","year":"2012","unstructured":"Prasad PK, Signorello LB, Friedman DL, Boice JD, Pukkala E. Long-term non\u2010cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer. 2012;58:421\u20137. https:\/\/doi.org\/10.1002\/pbc.23296.","journal-title":"Pediatr Blood Cancer"},{"key":"5008_CR9","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/annonc\/mdu260","volume":"25","author":"E Van Cutsem","year":"2014","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25:iii1\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdu260.","journal-title":"Ann Oncol"},{"key":"5008_CR10","doi-asserted-by":"publisher","first-page":"v70","DOI":"10.1093\/annonc\/mdq168","volume":"21","author":"R Labianca","year":"2010","unstructured":"Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A. Primary colon cancer: ESMO clinical practice guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21:v70\u20137. https:\/\/doi.org\/10.1093\/annonc\/mdq168.","journal-title":"Ann Oncol"},{"key":"5008_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/aje\/kwaa203","volume":"190","author":"C Dolladille","year":"2021","unstructured":"Dolladille C, Launoy G, Bouvier V, Salem JE, Legallois D, Milliez P, et al. Association between use of anticancer drugs and cardiovascular disease-related hospitalization in metastatic colorectal cancer: insights from a population-based study, the anticancer vigilance of cardiac events study. AM J EPIDEMIOL. 2021;190:376\u201385. https:\/\/doi.org\/10.1093\/aje\/kwaa203.","journal-title":"AM J EPIDEMIOL"},{"key":"5008_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","volume":"85","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*. Bull World Health Organ. 2007;85:867\u201372. https:\/\/doi.org\/10.2471\/BLT.07.045120.","journal-title":"Bull World Health Organ"},{"key":"5008_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2017.74.9739","volume":"36","author":"KM Kenzik","year":"2018","unstructured":"Kenzik KM, Balentine C, Richman J, Kilgore M, Bhatia S, Williams GR. New-onset cardiovascular morbidity in older adults with stage I to III colorectal cancer. JCO. 2018;36:609\u201316. https:\/\/doi.org\/10.1200\/JCO.2017.74.9739.","journal-title":"JCO"},{"key":"5008_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12957-021-02125-5","volume":"19","author":"CY Koo","year":"2021","unstructured":"Koo CY, Tai B-C, Chan DKH, Tan LL, Tan KK, Lee C-H. Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection. World J Surg Onc. 2021;19:21. https:\/\/doi.org\/10.1186\/s12957-021-02125-5.","journal-title":"World J Surg Onc"},{"key":"5008_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jclinpath-2013-202148","volume":"67","author":"J Budczies","year":"2014","unstructured":"Budczies J, Von Winterfeld M, Klauschen F, Kimmritz A-C, Daniel J-M, Warth A, et al. Comprehensive analysis of clinico-pathological data reveals heterogeneous relations between atherosclerosis and cancer. J Clin Pathol. 2014;67:482\u201390. https:\/\/doi.org\/10.1136\/jclinpath-2013-202148.","journal-title":"J Clin Pathol"},{"key":"5008_CR16","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1007\/s12325-021-01854-z","volume":"38","author":"T Matsumoto","year":"2021","unstructured":"Matsumoto T, Saito Y, Saito K, Tateishi K, Kato K, Kitahara H, et al. Relation between cancer and vasospastic angina. Adv Ther. 2021;38:4344\u201353. https:\/\/doi.org\/10.1007\/s12325-021-01854-z.","journal-title":"Adv Ther"},{"key":"5008_CR17","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490\u2013502. https:\/\/doi.org\/10.1016\/S0140-6736(13)61649-9.","journal-title":"Lancet"},{"key":"5008_CR18","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.jacc.2017.02.065","volume":"69","author":"D Niederseer","year":"2017","unstructured":"Niederseer D, Stadlmayr A, Huber-Sch\u00f6nauer U, Pl\u00f6derl M, Schmied C, Lederer D, et al. Cardiovascular risk and known coronary artery disease are associated with colorectal adenoma and advanced neoplasia. J Am Coll Cardiol. 2017;69:2348\u201350. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.065.","journal-title":"J Am Coll Cardiol"},{"key":"5008_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin. 2016;66:309\u201325. https:\/\/doi.org\/10.3322\/caac.21341.","journal-title":"CA Cancer J Clin"},{"key":"5008_CR20","doi-asserted-by":"publisher","unstructured":"Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B et al. Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention. JCO (2018) 36:2135\u201344. https:\/\/doi.org\/10.1200\/JCO.2017.76.3920","DOI":"10.1200\/JCO.2017.76.3920"},{"key":"5008_CR21","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2019.20012","author":"EM Hau","year":"2019","unstructured":"Hau EM, Caccia JN, Kasteler R, Spycher B, Suter T, Ammann RA, et al. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study. Swiss Med Wkly. 2019. https:\/\/doi.org\/10.4414\/smw.2019.20012.","journal-title":"Swiss Med Wkly"},{"key":"5008_CR22","doi-asserted-by":"publisher","first-page":"9604","DOI":"10.1016\/s0140-6736(07)61866-2","volume":"370","author":"QUASAR Collaborative Group","year":"2007","unstructured":"QUASAR Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet. 2007;370:9604. https:\/\/doi.org\/10.1016\/s0140-6736(07)61866-2.","journal-title":"Lancet"},{"key":"5008_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359251368069","volume":"17","author":"O Karhan","year":"2025","unstructured":"Karhan O, \u0130leri S, Urak\u00e7\u0131 Z, et al. Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study. Ther Adv Med Oncol. 2025;17:1\u201311. https:\/\/doi.org\/10.1177\/17588359251368069.","journal-title":"Ther Adv Med Oncol"},{"key":"5008_CR24","doi-asserted-by":"publisher","unstructured":"Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care\u2019s Gastrointestinal Cancer Disease Site Group. J Clin Oncol. 2004;22(16). https:\/\/doi.org\/10.1200\/jco.2004.03.087.","DOI":"10.1200\/jco.2004.03.087"},{"key":"5008_CR25","doi-asserted-by":"publisher","unstructured":"Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1). https:\/\/doi.org\/10.1007\/s10147-019-01485-z.","DOI":"10.1007\/s10147-019-01485-z"},{"key":"5008_CR26","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jama.298.12.1412","volume":"298","author":"AOO Chan","year":"2007","unstructured":"Chan AOO, Jim MH, Lam KF, Morris JS, Siu DCW, Tong T, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007;298:1412. https:\/\/doi.org\/10.1001\/jama.298.12.1412.","journal-title":"JAMA"},{"key":"5008_CR27","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105. https:\/\/doi.org\/10.1038\/nrdp.2017.105.","journal-title":"Nat Rev Dis Primers"},{"key":"5008_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","volume":"118","author":"SN Bhupathiraju","year":"2016","unstructured":"Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circul Res. 2016;118:1723\u201335. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306825.","journal-title":"Circul Res"},{"key":"5008_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/jcp.24234","volume":"228","author":"F De Nigris","year":"2013","unstructured":"De Nigris F, Mancini FP, Schiano C, Infante T, Zullo A, Minucci PB, et al. Osteosarcoma cells induce endothelial cell proliferation during neoangiogenesis. J Cell Physiol. 2013;228:846\u201352. https:\/\/doi.org\/10.1002\/jcp.24234.","journal-title":"J Cell Physiol"},{"key":"5008_CR30","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhuang X, Chen B, Wei M. Osteoglycin knockdown promotes vascular smooth muscle cell proliferation and migration in aortic dissection via the VEGF\/VEGFR2 axis. Mol Med Rep. 2020;23(65). https:\/\/doi.org\/10.3892\/mmr.2020.11703.","DOI":"10.3892\/mmr.2020.11703"},{"key":"5008_CR31","doi-asserted-by":"publisher","unstructured":"Kenzik KM, Balentine C, Richman J, Kilgore M, Bhatia S, Williams GR. New-Onset Cardiovascular Morbidity in Older Adults With Stage I to III Colorectal Cancer. J Clin Oncol. 2018;36(6). https:\/\/doi.org\/10.1200\/jco.2017.74.9739.","DOI":"10.1200\/jco.2017.74.9739"},{"issue":"2","key":"5008_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000072338","volume":"65","author":"M Roselli","year":"2003","unstructured":"Roselli M, Guadagni F, Martini F, Spila A, Mariotti S, D\u2019Alessandro R, et al. Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer. Oncology. 2003;65(2):132\u20138. https:\/\/doi.org\/10.1159\/000072338.","journal-title":"Oncology"},{"issue":"11","key":"5008_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1080\/003655299750024959","volume":"34","author":"H Ito","year":"1999","unstructured":"Ito H, Miki C. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol. 1999;34(11):1139\u201343. https:\/\/doi.org\/10.1080\/003655299750024959.","journal-title":"Scand J Gastroenterol"},{"key":"5008_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1161\/CIRCRESAHA.120.317062","volume":"127","author":"R Zahreddine","year":"2020","unstructured":"Zahreddine R, Davezac M, Smirnova N, Buscato M, Lhuillier E, Lupieri A, et al. Tamoxifen Accelerates Endothelial Healing by Targeting ER\u03b1 in Smooth Muscle Cells. Circul Res. 2020;127:1473\u201387. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317062.","journal-title":"Circul Res"},{"key":"5008_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/annonc\/mdy035","volume":"29","author":"JC Trone","year":"2018","unstructured":"Trone JC, Ollier E, Chapelle C, Bertoletti L, Cucherat M, Mismetti P, et al. Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events\u2014a meta-analysis. Ann Oncol. 2018;29:803\u201311. https:\/\/doi.org\/10.1093\/annonc\/mdy035.","journal-title":"Ann Oncol"},{"key":"5008_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00280-019-03844-z","volume":"84","author":"DVT Wong","year":"2019","unstructured":"Wong DVT, Ribeiro-Filho HV, Wanderley CWS, et al. SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4. Cancer Chemother Pharmacol. 2019;84:287\u201398. https:\/\/doi.org\/10.1007\/s00280-019-03844-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"5008_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1532832","author":"MHK Roshan","year":"2016","unstructured":"Roshan MHK, Tambo A, Pace NP. The role of TLR2, TLR4, and TLR9 in the pathogenesis of atherosclerosis. Int J Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/1532832.","journal-title":"Int J Inflamm"},{"key":"5008_CR38","doi-asserted-by":"publisher","first-page":"F191","DOI":"10.1152\/ajprenal.00015.2009","volume":"297","author":"F Helle","year":"2009","unstructured":"Helle F, Jouzel C, Chadjichristos C, et al. Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism. Am J Physiol Renal Physiol. 2009;297:F191\u20139. https:\/\/doi.org\/10.1152\/ajprenal.00015.2009.","journal-title":"Am J Physiol Renal Physiol"},{"key":"5008_CR39","unstructured":"Melichar B, Kal\u00e1bov\u00e1 H, Krcmov\u00e1 L, Kasparov\u00e1 M, Mal\u00edrov\u00e1 E, Melicharov\u00e1 K et al. Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin. Anticancer research."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05008-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:51:31Z","timestamp":1780969891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05008-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05008-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is based on a public database with de-identified data and does not involve research protocol requiring approval by the relevant institutional review board or ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"876"}}